KCKatherine Cianflone

Katherine Cianflone

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Katherine Cianflone has a total of 106 co-authors. Here are the top co-authors by number of shared publications:

  • Marc Lapointe

    Centre de Recherche Institut Universitaire de Cardiologie & Pneumologie de Québec, Université Laval, Québec, Canada

    14 shared publications
  • Abhishek Gupta

    8 shared publications
  • Christian Roy

    Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Québec (CRIUCPQ), Québec, QC, Canada; Department of Medicine, Laval University, Québec, QC, Canada

    7 shared publications
  • Pegah Poursharifi

    Montreal Diabetes Research Center - Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Montréal, Canada

    7 shared publications
  • Danny Gauvreau

    Institut Universitaire de Cardiologie et de Pneumologie de Québec Research Center (CRIUCPQ), Laval University, Quebec, Quebec, Canada

    5 shared publications
  • Pierre Miegueu

    Centre de Recherche Institut Universitaire de Cardiologie & Pneumologie de Québec, Université Laval, Québec, Canada

    5 shared publications

Latest Publications

  • Genetic variants of the adiponectin gene and its association with adiponectin level in metabolic syndrome women

    by Abhishek Gupta, Sunita Tiwari, Suraksha Agrawal, Arun Kumar Singh, Bhola Nath Paul, Katherine Cianflone

    Background: Adiponectin is an adipocyte-derived adipokine, down-regulated in obesity linked disorders. Here, we investigated the genotypic variability of adiponectin (at position; +T45G and +G276T) and its association with circulating adiponectin and metabolic syndrome in North Indian adult women. Methods: We compared metabolic syndrome (MetS; 269) women to without metabolic syndrome (wMetS; 272) women of North India. Genotype frequencies of the adiponectin gene were performed using PCR-RFLP method and circulating adiponectin estimated by sandwich ELISA method. Results: Low level of adiponectin (PPP=0.017) while mutant G allele was significantly high (P=0.008) in MetS women as respective to wild type. However, frequency of mutant T allele in MetS women was found to be significantly (P=0.027) less as compared to wMetS at position +276G/T of adiponectin gene. The mutant genotype GG of +45T/G and TT of +276G/T of adiponectin were significantly associated with lower adiponectin level and higher HOMA-IR (all P<0.001) in adult metabolic syndrome. Conclusions: Results suggest that adiponectin gene variants might be associated with lower adiponectin level and metabolic syndrome.

  • Erratum to: C3 Polymorphism Influences Circulating Levels of C3, ASP and Lipids in Schizophrenic Patients

    by Mohamed Jalloul Nsaibia, Marc Lapointe, Hajer Mabrouk, Wahiba Douki, Lotfi Gaha, Louis Pérusse, Claude Bouchard, Besma Bel Hadj Jrad, Katherine Cianflone

  • C3 Polymorphism Influences Circulating Levels of C3, ASP and Lipids in Schizophrenic Patients

    by Mohamed Jalloul Nsaiba, Marc Lapointe, Hajer Mabrouk, Wahiba Douki, Lotfi Gaha, Louis Pérusse, Claude Bouchard, Besma Bel Hadj Jrad, Katherine Cianflone

    Excessive activation of complement is associated with many diseases including schizophrenia. Investigation of C3 polymorphisms, circulating C3, cleavage product ASP/C3adesArg, and lipid metabolism. Cross-sectional analysis. C3 genotyping (CC vs GG for R102L) was performed on 434 Tunisian people consisting of 272 schizophrenic (SZ) patients and 162 control subjects. In a age-and gender-matched subgroups of the three genotypes (131 SZ and 112 NOR), plasma triglycerides, total cholesterol (C), LDL-C, HDL-C, ASP, and complement C3 were measured. C3 gene polymorphism influences BMI and plasma C3, ASP, triglyceride, total cholesterol, LDL-C and HDL-C among SZ patients (p < 0.05-0.0001), with increasing values demonstrated from CC (common form) to CG (heterozygote form) to GG (rare homozygote) forms. Significant correlations between plasma C3 and BMI, triglyceride, HDL-C and ASP (p < 0.05-0.0001) were observed, while ASP correlated with BMI and LDL-C (p = 0.005, p = 0.001, respectively) in SZ patients. Further, proportional conversion of C3 to ASP (% ASP/C3) also increased (p < 0.0001, GG>CG>CC). C3 polymorphisms and plasma C3, ASP and % ASP/C3 correlated with lipid parameters in this SZ population, suggesting that factors predisposing patients to schizophrenia are permissive for complement pathway activation and dyslipidemic influences.


  • Changes in circulating adiponectin, leptin, glucose and C‐peptide in patients with ketosis‐prone diabetes

    by P. Gupta, Y. Liu, M. Lapointe, T. Yotsapon, S. Sarat, K. Cianflone

    Aims: To evaluate circulating adipokines in people with ketosis‐prone diabetes, a heterogeneous disorder characterized by unprovoked ketoacidosis in people with previously unrecognized diabetes.Methods: Patients presenting with ketoacidosis with no previous diabetes diagnosis were compared with patients with previously established Type 1 diabetes. Baseline assessments of autoimmune status (A+/A‐), and β‐cell function (B+/B‐), as well as leptin and adiponectin levels during a standardized mixed‐meal tolerance test of 120 min, were performed. In all, 20 patients with heterogeneous ketosis‐prone diabetes and 12 patients with Type 1 diabetes were evaluated at baseline, 12 and 24 months.Results: At baseline, during a mixed‐meal tolerance test, glucose and adiponectin concentrations were lower in patients with ketosis‐prone diabetes than in those with Type 1 diabetes (P = 0.0023 and P < 0.0001, respectively), whereas C‐peptide concentrations were higher, with no significant difference in leptin concentrations. Within 12 months, 11 patients with ketosis‐prone diabetes (all A‐/B+) were discontinued from insulin treatment (ketosis‐prone diabetes ‐ insulin group), while nine patients (four A‐B‐, four A+B‐ and one A‐B+) were maintained on insulin (ketosis‐prone diabetes + insulin group). Fasting C‐peptide levels increased significantly over 24 months in the ketosis‐prone diabetes ‐ insulin group (P = 0.01), while HbA1c levels decreased (P < 0.0001). Overall, the ketosis‐prone diabetes ‐ insulin group had a higher BMI (P = 0.018), yet a lower fasting glucose concentration (P = 0.003) compared with the ketosis‐prone diabetes + insulin group. Over 24 months, the mixed‐meal tolerance test area‐under‐the‐curve of C‐peptide increased in the ketosis‐prone diabetes ‐ insulin group, with no change in ketosis‐prone diabetes + insulin (P < 0.0001). At 24 months, in spite of the higher BMI in the ketosis‐prone diabetes ‐ insulin group, mixed‐meal tolerance test glucose and leptin concentrations were significantly lower (P < 0.0001 and P = 0.017, respectively), while adiponectin levels were higher (P = 0.023) compared with the ketosis‐prone diabetes + insulin group.Conclusions: In spite of the higher BMI in the ketosis‐prone diabetes ‐ insulin group, lower leptin and higher adiponectin levels may contribute to improved β‐cell function and insulin sensitivity, as evidenced by lower glucose and higher C‐peptide levels. This allows insulin therapy to be withdrawn.


  • Open Access

    Increased Vaspin Levels Are Associated with Beneficial Metabolic Outcome Pre- and Post-Bariatric Surgery

    by HuiLing Lu, Ponce Cedric Fouejeu Wamba, Marc Lapointe, Paul Poirier, Julie Martin, Marjorie Bastien, Katherine Cianflone

    Vaspin (visceral-adipose-tissue-derived-serine-protease-inhibitor) is a recently identified adipokine with putative insulin-sensitizing properties. Plasma vaspin responses to surgery-induced weight loss are sparse and contradictory. We evaluated changes in vaspin levels and relationship to post-operative outcomes in men (n = 22) and women (n = 55) undergoing biliopancreatic-diversion/duodenal-switch bariatric surgery. Body composition and plasma parameters were measured at baseline, acutely (1 and 5 days) and medium-term (6 and 12 months) post-surgery. Fasting preoperative vaspin concentrations were comparable in men vs women. The distribution was biphasic (both men and women) with a nadir of 2.5 ng/ml. Subjects were divided into high (≥2.5 ng/mL, HI-group) and low (<2.5 ng/mL, LO-group) vaspin level. Both groups had comparable sex distribution, age and BMI, but the HI-vaspin group had lower insulin, HOMA, and triglyceride and higher HDL-cholesterol, acylation stimulating protein (ASP) and IL-6 levels (all p<0.05). Post-operatively, both groups decreased BMI comparably over 12 months; the HI-vaspin group maintained high vaspin levels, while the LO-vaspin group gradually increased their levels with weight loss over 12 months. The HI-vaspin group maintained a better glucose, insulin, HOMA, fructosamine, HDL-cholesterol, and triglyceride profile throughout. The HI-vaspin group also had higher gamma-glutamyltransferase and ASP profiles. Finally, baseline vaspin level inversely correlated significantly with baseline and 12-month insulin, HOMA, triglyceride and positively correlated with HDL and ASP. Twelve-month vaspin also correlated similarly, including an inverse correlation with BMI. Globally, this study supports the concept of vaspin as a beneficial adipokine in obesity, which may potentially lead to possible therapeutic targets.


  • Open Access

    Acylation Stimulating Protein, Complement C3 and Lipid Metabolism in Ketosis-Prone Diabetic Subjects

    by Yan Liu, Priyanka Gupta, Marc Lapointe, Thewjitcharoen Yotsapon, Sunthornyothin Sarat, Katherine Cianflone

    Ketosis-prone diabetes (KPDM) is new-onset diabetic ketoacidosis without precipitating factors in non-type 1 diabetic patients; after management, some are withdrawn from exogenous insulin, although determining factors remain unclear. Twenty KPDM patients and twelve type 1 diabetic patients (T1DM), evaluated at baseline, 12 and 24 months with/without insulin maintenance underwent a standardized mixed-meal tolerance test (MMTT) for 2 h. At baseline, triglyceride and C3 were higher during MMTT in KPDM vs. T1DM (p<0.0001) with no differences in non-esterified fatty acids (NEFA) while Acylation Stimulating Protein (ASP) tended to be higher. Within 12 months, 11 KPDM were withdrawn from insulin treatment (KPDM-ins), while 9 were maintained (KPDM+ins). NEFA was lower in KPDM-ins vs. KPDM+ins at baseline (p = 0.0006), 12 months (p<0.0001) and 24 months (p<0.0001) during MMTT. NEFA in KPDM-ins decreased over 30–120 minutes (p<0.05), but not in KPDM+ins. Overall, C3 was higher in KPDM-ins vs KPDM+ins at 12 months (p = 0.0081) and 24 months (p = 0.0019), while ASP was lower at baseline (p = 0.0024) and 12 months (p = 0.0281), with a decrease in ASP/C3 ratio. Notwithstanding greater adiposity in KPDM-ins, greater NEFA decreases and lower ASP levels during MMTT suggest better insulin and ASP sensitivity in these patients.


  • Open Access

    Omentin changes following bariatric surgery and predictive links with biomarkers for risk of cardiovascular disease

    by Marc Lapointe, Paul Poirier, Julie Martin, Marjorie Bastien, Audrey Auclair, Katherine Cianflone

    Although no receptor has yet been identified, changes in circulating levels of the adipokine designated as Omentin have been demonstrated in obesity and related comorbidities such as cardiovascular disease, insulin resistance, metabolic syndrome and chronic inflammation. Changes in Omentin levels at 1 and 5 days and 6 and 12 months in response to biliopancreatic diversion with duodenal switch bariatric surgery were evaluated, specifically to investigate if changes preceded gain of insulin sensitivity. Pre-operative plasma Omentin was not different between men (n = 18) vs women (n = 48), or diabetic status but correlated with body mass index (BMI). Altogether, Omentin increased as early as 24-h post-surgery, with changes maintained up to 1-year. Fifty-nine percent of subjects increased Omentin >10% by 24-H following surgery (OmentinINC p < 0.0001), while 18% of subjects decreased (OmentinDEC p < 0.0001), with changes maintained throughout one-year. These two groups had comparable age, sex distribution, diabetes, BMI, waist circumference and fat mass, however OmentinDEC had elevated levels of cardiovascular risk markers; homocysteine (p = 0.019), NT-proBNP (p = 0.006) and total bilirubin (p = 0.0001) while red blood cell (RBC) count was lower (p = 0.0005) over the one-year period. Omentin levels at 1-DAY also correlated with immune parameters (white blood cell count, % neutrophil, % monocytes, % lymphocytes). OmentinDEC at 1 day following surgery may be a marker of cardiovascular “at-risk” group before weight loss or insulin sensitivity restoration.


  • Cross‐sectional associations of acylation stimulating protein (ASP) and adipose tissue gene expression with estradiol and progesterone in pre‐ and postmenopausal women

    by Reza Rezvani, Abhishek Gupta, Jessica Smith, Pegah Poursharifi, Picard Marceau, Louis Pérusse, Claude Bouchard, André Tchernof, Katherine Cianflone

    Summary: Objective: Sex steroid hormones play an important regulatory role in fat metabolism and obesity. We hypothesized involvement of interactions between ovarian hormones with acylation stimulating protein (ASP).Design, patients and measurements: In 392 women with wide age (18–69 years) and body size (BMI: 17 to 90 kg/m2) ranges, fasting plasma levels of ASP, ovarian hormones, glucose, adiponectin and lipids/apolipoproteins were assessed, along with determination of metabolic syndrome (MS) features. Gene expression of C3 (ASP precursor) and related receptors C5L2, C3aR and C5aR in subcutaneous and omental adipose tissues was measured in a subset.Results: Acylation stimulating protein correlated negatively with concentrations of estradiol (P < 0·0001), adiponectin (P < 0·001) and apolipoprotein A1 (P < 0·001) and positively with apolipoprotein B levels (P < 0·001), systolic blood pressure (P < 0·001), waist circumference (P < 0·001), and triglyceride concentrations (P < 0·01). In age‐matched groups of lean, overweight, metabolically healthy obese (MHO) and obese with metabolic syndrome (MSO), there was a stepwise increase in ASP levels (P < 0·001) while concentrations of adiponectin (P < 0·0001) and estradiol (P < 0·001) but not those of progesterone decreased. Progesterone but not estradiol levels correlated positively with C3 gene expression in omental adipose tissue (P < 0·05) and negatively with C5L2 expression in both omental (P < 0·01) and subcutaneous (P < 0·05) adipose tissues.Conclusion: Our results are consistent with the concept that sex hormones differentially influence circulating ASP and adipose tissue gene expression of its related proteins in a depot‐specific manner. ASP may play a role in the regulation of regional fat metabolism through interactions with sex hormones in women.


  • Open Access

    Downregulation of Complement C3 and C3aR Expression in Subcutaneous Adipose Tissue in Obese Women

    by Abhishek Gupta, Reza Rezvani, Marc Lapointe, Pegah Poursharifi, Picard Marceau, Sunita Tiwari, Andre Tchernof, Katherine Cianflone

    The central component of the complement system, C3, is associated with obesity, metabolic syndrome and cardiovascular disease however the underlying reasons are unknown. In the present study we evaluated gene expression of C3, the cleavage product C3a/C3adesArg and its cognate receptor C3aR in subcutaneous and omental adipose tissue in women. Women (n = 140, 21–69 years, BMI 19.5–79 kg/m2) were evaluated for anthropometric and blood parameters, and adipose tissue gene expression. Subjects were separated into groups (n = 34–36) according to obesity: normal/overweight (≤30 kg/m2), obese I (≤45 kg/m2), obese II (≤51 kg/m2), and obese III (≤80 kg/m2). Overall, while omental expression remained unchanged, subcutaneous C3 and C3aR gene expression decreased with increasing adiposity (2-way ANOVA, p<0.01), with a concomitant decrease in SC/OM ratio (p<0.001). In subcutaneous adipose, both C3 and C3aR expression correlated with apoB, and apoA1 and inversely with waist circumference and blood pressure, while C3aR also correlated with glucose (p<0.05–0.0001). While omental C3aR expression did not correlate with any factor, omental C3 correlated with waist circumference, glucose and apoB (all p<0.05). Further, while plasma C3a/C3adesArg increased and adiponectin decreased with increasing BMI, both correlated (C3a negatively and adiponectin positively) with subcutaneous C3 and C3aR expression (p<0.05–0.001) or less). The obesity-induced down-regulation of complement C3 and C3aR which is specific to subcutaneous adipose tissue, coupled to the strong correlations with multiple anthropometric, plasma and adipokine variables support a potential role for complement in immunometabolism.


  • Open Access

    Complement Receptors C5aR and C5L2 Are Associated with Metabolic Profile, Sex Hormones, and Liver Enzymes in Obese Women Pre- and Postbariatric Surgery

    by Reza Rezvani, Jessica Smith, Marc Lapointe, Picard Marceau, Andre Tchernof, Katherine Cianflone

    Objective. Obesity is associated with metabolic dysfunction with sex differences and chronic, low-grade inflammation. We proposed that hepatic expression of immune complement C3 related receptors (C3aR, C5aR, and C5L2) would be associated with pre- or postmenopausal status and metabolic profile in severely obese women. We hypothesized that C5L2/C5aR ratio, potentially influencing the ASP/C5L2 metabolic versus C5a/C5aR immune response, would predict metabolic profiles after weight loss surgery.Materials and Methods. Fasting plasma (hormone, lipid, and enzyme analysis) and liver biopsies (RT-PCR gene expression) were obtained from 91 women during surgery.Results. Hepatic C5L2 mRNA expression was elevated in pre- versus postmenopausal women (P<0.01) and correlated positively with circulating estradiol, estrone, ApoB, ApoA1, ApoA1/B, waist circumference, age, and LDL-C (allP<0.05). While plasma ASP was lower in pre- versus postmenopausal women (P<0.01), the hepatic C5L2/C5aR mRNA ratio was increased (P<0.001) and correlated positively with estrone (P<0.01) and estradiol (P<0.001) and negatively with circulating ApoB and liver enzymes ALT, AST, and GGT (allP<0.05). Over 12 months postoperatively, liver enzymes in low C5L2/C5aR mRNA ratio group remained higher (ALP and ALT,P<0.05, AST and GGT,P<0.0012-way-ANOVA).Conclusion. C5L2-C5aR association with other mediators including estrogens may contribute to hepatic metabolic and inflammatory function.